サマリー

世界のガンマブチロラクトン市場は、2023年から2030年の予測期間に3.1%のCAGRを記録すると予測されます。この新しい市場レポートは、歴史的な年2021年のデータを含み、計算の基準年は2022年であり、予測期間は2023年から2030年です。

市場細分化：
ガンマブチロラクトンの世界市場：グレード別（工業用クラス（5重量%）、電気容量クラス（9重量%）、一般クラス（8重量%））、純度別（99.9%以上、99.7%未満）。7％）、用途（溶剤、鋳造用バインダー、除草剤・殺虫剤、電池・コンデンサ、塗料剥離剤、研磨剤、麻酔剤、鎮静剤、その他）、最終用途（医薬品業界、電機業界、農薬業界、石油業界、食品業界、その他）、国（U.S．カナダ、メキシコ、英国、イタリア、フランス、スペイン、ロシア、スイス、トルコ、ベルギー、ルクセンブルク、オランダ、その他ヨーロッパ、日本、中国、韓国、インド、シンガポール、タイ、インドネシア、マレーシア、フィリピン、オーストラリア、ニュージーランド、その他アジア太平洋、ブラジル、アルゼンチン、その他南米、南アフリカ、エジプト、サウジアラビア、アラブ首長国連邦、イスラエル、その他中東・アフリカ） 産業動向と2030年までの予測
世界のガンマブチロラクトン市場の成長に寄与する主な要因の一部をご紹介します：

- 医薬品の製造における応用
- マニキュアリムーバーの使用量と需要の増加

市場のプレーヤー：

世界のガンマブチロラクトン市場で活動している主なプレイヤーは以下の通りです：
- Zhejiang Realsun Chemical Co.Ltd.（浙江省）、Biosynth, Inc.
- バイオシンス
- BYNケミカル(株)
- DCC
- BASF SE
- アシュランド
- ボアイNKYファーマシューティカルズ株式会社
- 三菱化学株式会社
- シプケム社
- バラジ・アミン

ページTOPに戻る

目次

TABLE OF CONTENTS
1 INTRODUCTION 22
1.1 OBJECTIVES OF THE STUDY 22
1.2 MARKET DEFINITION 22
1.3 OVERVIEW OF THE GLOBAL GAMMA BUTYROLACTONE MARKET 22
1.4 LIMITATIONS 23
1.5 MARKETS COVERED 24
2 MARKET SEGMENTATION 27
2.1 MARKETS COVERED 27
2.2 GEOGRAPHICAL SCOPE 28
2.3 YEARS CONSIDERED FOR THE STUDY 29
2.4 CURRENCY AND PRICING 29
2.5 DBMR TRIPOD DATA VALIDATION MODEL 30
2.6 GRADE LIFE LINE CURVE 33
2.7 MULTIVARIATE MODELING 34
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 35
2.9 DBMR MARKET POSITION GRID 36
2.10 MARKET END-USE COVERAGE GRID 37
2.11 DBMR MARKET CHALLENGE MATRIX 38
2.12 DBMR VENDOR SHARE ANALYSIS 39
2.13 IMPORT-EXPORT DATA 40
2.14 SECONDARY SOURCES 41
2.15 ASSUMPTIONS 42
3 EXECUTIVE SUMMARY 43
4 PREMIUM INSIGHTS 46
4.1 PESTLE ANALYSIS 48
4.1.1 POLITICAL FACTORS 48
4.1.2 ECONOMIC FACTORS 49
4.1.3 SOCIAL FACTORS 49
4.1.4 TECHNOLOGICAL FACTORS 49
4.1.5 LEGAL FACTORS 49
4.1.6 ENVIRONMENTAL FACTORS 49
4.2 PORTER'S FIVE FORCES: 50
4.2.1 THREAT OF NEW ENTRANTS: 50
4.2.2 THREAT OF SUBSTITUTES: 50
4.2.3 CUSTOMER BARGAINING POWER: 51
4.2.4 SUPPLIER BARGAINING POWER: 51
4.2.5 INTERNAL COMPETITION (RIVALRY): 51
4.3 CLIMATE CHANGE SCENARIO 52
4.3.1 ENVIRONMENTAL CONCERNS 52
4.3.2 INDUSTRY RESPONSE 52
4.3.3 GOVERNMENT'S ROLE 52
4.3.4 ANALYST RECOMMENDATION 52
4.4 LIST OF KEY PATENTS LAUNCHED 53
4.5 SUPPLY CHAIN ANALYSIS 54
4.5.1 OVERVIEW 54
4.5.2 LOGISTIC COST SCENARIO 54
4.5.3 IMPORTANCE OF LOGISTICS SERVICE PROVIDERS 55
4.6 VENDOR SELECTION CRITERIA 56
5 MARKET OVERVIEW 57
5.1 DRIVERS 59
5.1.1 GROWING APPLICATION OF DERIVED CHEMICAL PRODUCTS 59
5.1.2 APPLICATION IN A WIDE RANGE OF INDUSTRIES 59
5.1.3 INCREASED DEMAND FOR ELECTRONIC ITEMS 60
5.2 RESTRAINTS 61
5.2.1 SERIOUS HEALTH EFFECTS AND SAFETY CONCERNS 61
5.2.2 STRINGENT RULES AND REGULATIONS 61
5.3 OPPORTUNITIES 62
5.3.1 RISE IN DEMAND FOR ELECTRIC VEHICLES 62
5.3.2 INCREASE IN USAGE OF ORGANIC AGROCHEMICALS 62
5.4 CHALLENGES 63
5.4.1 GOVERNMENT RESTRICTIONS FOR ILLEGAL USAGE 63
6 GLOBAL GAMMA BUTYROLACTONE MARKET, BY GRADE 64
6.1 OVERVIEW 65
6.2 INDUSTRIAL CLASS (5 WT.%) 67
6.3 ELECTRIC CAPACITANCE CLASS (9 WT.%) 68
6.4 COMMON CLASS (8 WT.%) 69
7 GLOBAL GAMMA BUTYROLACTONE MARKET, BY PURITY 70
7.1 OVERVIEW 71
7.2 MIN. 99.9% 72
7.3 MIN. 99.7% 73
8 GLOBAL GAMMA BUTYROLACTONE MARKET, BY APPLICATION 74
8.1 OVERVIEW 75
8.2 SOLVENT 76
8.3 CASTING BINDER 77
8.4 HERBICIDES AND INSECTICIDES 77
8.5 BATTERIES AND CAPACITORS 78
8.6 PAINT STRIPPERS 79
8.7 POLISH REMOVERS 79
8.8 ANESTHETIC 80
8.9 SEDATIVE 81
8.10 OTHERS 82
9 GLOBAL GAMMA BUTYROLACTONE MARKET, BY END-USE 83
9.1 OVERVIEW 84
9.2 PHARMACEUTICAL INDUSTRY 85
9.3 ELECTRICAL INDUSTRY 86
9.4 AGROCHEMICAL INDUSTRY 87
9.5 PETROLEUM INDUSTRY 87
9.6 FOOD INDUSTRY 88
9.7 OTHERS 89
10 GLOBAL GAMMA BUTYROLACTONE MARKET, BY REGION 90
10.1 OVERVIEW 91
10.2 ASIA-PACIFIC 96
10.2.1 CHINA 102
10.2.2 INDIA 104
10.2.3 JAPAN 106
10.2.4 SOUTH KOREA 108
10.2.5 SINGAPORE 110
10.2.6 THAILAND 112
10.2.7 AUSTRALIA & NEW ZEALAND 114
10.2.8 INDONESIA 116
10.2.9 MALAYSIA 118
10.2.10 PHILIPPINES 120
10.2.11 REST OF ASIA-PACIFIC 122
10.3 EUROPE 123
10.3.1 FRANCE 129
10.3.2 GERMANY 131
10.3.3 U.K. 133
10.3.4 ITALY 135
10.3.5 TURKEY 137
10.3.6 BELGIUM 139
10.3.7 SPAIN 141
10.3.8 RUSSIA 143
10.3.9 SWITZERLAND 145
10.3.10 NETHERLANDS 147
10.3.11 REST OF EUROPE 149
10.4 NORTH AMERICA 150
10.4.1 U.S. 155
10.4.2 CANADA 157
10.4.3 MEXICO 159
10.5 SOUTH AMERICA 161
10.5.1 BRAZIL 166
10.5.2 ARGENTINA 168
10.5.3 REST OF SOUTH AMERICA 170
10.6 MIDDLE EAST AND AFRICA 171
10.6.1 SOUTH AFRICA 177
10.6.2 SAUDI ARABIA 179
10.6.3 UNITED ARAB EMIRATES 181
10.6.4 ISRAEL 183
10.6.5 EGYPT 185
10.6.6 REST OF MIDDLE EAST AND AFRICA 187
11 GLOBAL GAMMA BUTYROLACTONE MARKET: COMPANY LANDSCAPE 188
11.1 COMPANY SHARE ANALYSIS: GLOBAL 188
11.2 COMPANY SHARE ANALYSIS: NORTH AMERICA 189
11.3 COMPANY SHARE ANALYSIS: EUROPE 190
11.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 191
11.5 RECOGNITION 192
11.6 AWARD 192
11.7 EVENT 193
11.8 EXPANSION 193
11.9 AGREEMENT 193
12 SWOT ANALYSIS 194
13 COMPANY PROFILES 195
13.1 MITSUBISHI CHEMICAL CORPORATION. 195
13.1.1 COMPANY SNAPSHOT 195
13.1.2 REVENUE ANALYSIS 195
13.1.3 COMPANY SHARE ANALYSIS 196
13.1.4 PRODUCT PORTFOLIO 196
13.1.5 RECENT DEVELOPMENTS 196
13.2 BASF SE 197
13.2.1 COMPANY SNAPSHOT 197
13.2.2 REVENUE ANALYSIS 197
13.2.3 COMPANY SHARE ANALYSIS 198
13.2.4 PRODUCT PORTFOLIO 198
13.2.5 RECENT DEVELOPMENT 198
13.3 SIPCHEM COMPANY 199
13.3.1 COMPANY SNAPSHOT 199
13.3.2 REVENUE ANALYSIS 199
13.3.3 COMPANY SHARE ANALYSIS 200
13.3.4 PRODUCT PORTFOLIO 200
13.3.5 RECENT DEVELOPMENTS 200
13.4 BALAJI AMINES 202
13.4.1 COMPANY SNAPSHOT 202
13.4.2 REVENUE ANALYSIS 202
13.4.3 COMPANY SHARE ANALYSIS 203
13.4.4 PRODUCT PORTFOLIO 203
13.4.5 RECENT DEVELOPMENTS 203
13.5 ASHLAND 204
13.5.1 COMPANY SNAPSHOT 204
13.5.2 REVENUE ANALYSIS 204
13.5.3 COMPANY SHARE ANALYSIS 205
13.5.4 PRODUCT PORTFOLIO 205
13.5.5 RECENT DEVELOPMENT 205
13.6 BIOSYNTH 206
13.6.1 COMPANY SNAPSHOT 206
13.6.2 PRODUCT PORTFOLIO 206
13.6.3 RECENT DEVELOPMENT 206
13.7 BOAI NKY PHARMACEUTICALS LTD. 207
13.7.1 COMPANY SNAPSHOT 207
13.7.2 PRODUCT PORTFOLIO 207
13.7.3 RECENT DEVELOPMENT 207
13.8 BYN CHEMICALS CO., LTD 208
13.8.1 COMPANY SNAPSHOT 208
13.8.2 PRODUCT PORTFOLIO 208
13.8.3 RECENT DEVELOPMENT 208
13.9 DCC 209
13.9.1 COMPANY SNAPSHOT 209
13.9.2 PRODUCT PORTFOLIO 209
13.9.3 RECENT DEVELOPMENT 210
13.10 ZHEJIANG REALSUN CHEMICAL CO.,LTD. 211
13.10.1 COMPANY SNAPSHOT 211
13.10.2 PRODUCT PORTFOLIO 211
13.10.3 RECENT DEVELOPMENTS 211
14 QUESTIONNAIRE 212
15 RELATED REPORTS 215

ページTOPに戻る

図表リスト

LIST OF TABLES
TABLE 1 IMPORT DATA OF LACTONES; HS CODE – 293220 (USD THOUSAND) 40
TABLE 2 EXPORT DATA OF LACTONES; HS CODE – 293220 (USD THOUSAND) 40
TABLE 3 GLOBAL GAMMA BUTYROLACTONE MARKET, BY GRADE, 2017-2030 (USD THOUSAND) 66
TABLE 4 GLOBAL GAMMA BUTYROLACTONE MARKET, BY GRADE, 2017-2030 (TONS) 66
TABLE 5 GLOBAL INDUSTRIAL CLASS (5 WT.%) IN GAMMA BUTYROLACTONE MARKET, BY REGION, 2017-2030 (USD THOUSAND) 67
TABLE 6 GLOBAL INDUSTRIAL CLASS (5 WT.%) IN GAMMA BUTYROLACTONE MARKET, BY REGION, 2017-2030 (TONS) 67
TABLE 7 GLOBAL ELECTRIC CAPACITANCE CLASS (9 WT.%) IN GAMMA BUTYROLACTONE MARKET, BY REGION, 2017-2030 (USD THOUSAND) 68
TABLE 8 GLOBAL ELECTRIC CAPACITANCE CLASS (9 WT.%) IN GAMMA BUTYROLACTONE MARKET, BY REGION, 2017-2030 (TONS) 68
TABLE 9 GLOBAL COMMON CLASS (8 WT.%) IN GAMMA BUTYROLACTONE MARKET, BY REGION, 2017-2030 (USD THOUSAND) 69
TABLE 10 GLOBAL COMMON CLASS (8 WT.%) IN GAMMA BUTYROLACTONE MARKET, BY REGION, 2017-2030 (TONS) 69
TABLE 11 GLOBAL GAMMA BUTYROLACTONE MARKET, BY PURITY, 2017-2030 (USD THOUSAND) 72
TABLE 12 GLOBAL MIN. 99.9% IN GAMMA BUTYROLACTONE MARKET, BY REGION, 2017-2030 (USD THOUSAND) 72
TABLE 13 GLOBAL MIN. 99.7% IN GAMMA BUTYROLACTONE MARKET, BY REGION, 2017-2030 (USD THOUSAND) 73
TABLE 14 GLOBAL GAMMA BUTYROLACTONE MARKET, BY APPLICATION, 2017-2030 (USD THOUSAND) 76
TABLE 15 GLOBAL SOLVENT IN GAMMA BUTYROLACTONE MARKET, BY REGION, 2017-2030 (USD THOUSAND) 76
TABLE 16 GLOBAL CASTING BINDER IN GLOBAL GAMMA BUTYROLACTONE MARKET, BY REGION, 2017-2030 (USD THOUSAND) 77
TABLE 17 GLOBAL HERBICIDES AND INSECTICIDES IN GAMMA BUTYROLACTONE MARKET, BY REGION, 2017-2030 (USD THOUSAND) 78
TABLE 18 GLOBAL BATTERIES AND CAPACITORS IN GAMMA BUTYROLACTONE MARKET, BY REGION, 2017-2030 (USD THOUSAND) 78
TABLE 19 GLOBAL PAINT STRIPPERS IN GAMMA BUTYROLACTONE MARKET, BY REGION, 2017-2030 (USD THOUSAND) 79
TABLE 20 GLOBAL POLISH REMOVERS IN GAMMA BUTYROLACTONE MARKET, BY REGION, 2017-2030 (USD THOUSAND) 80
TABLE 21 GLOBAL ANESTHETIC IN GAMMA BUTYROLACTONE MARKET, BY REGION, 2017-2030 (USD THOUSAND) 80
TABLE 22 GLOBAL SEDATIVE IN GAMMA BUTYROLACTONE MARKET, BY REGION, 2017-2030 (USD THOUSAND) 81
TABLE 23 GLOBAL OTHERS IN GAMMA BUTYROLACTONE MARKET, BY REGION, 2017-2030 (USD THOUSAND) 82
TABLE 24 GLOBAL GAMMA BUTYROLACTONE MARKET, BY END-USE, 2017-2030 (USD THOUSAND) 85
TABLE 25 GLOBAL PHARMACEUTICAL INDUSTRY IN GLOBAL GAMMA BUTYROLACTONE MARKET, BY REGION, 2017-2030 (USD THOUSAND) 85
TABLE 26 GLOBAL ELECTRICAL INDUSTRY IN GAMMA BUTYROLACTONE MARKET, BY REGION, 2017-2030 (USD THOUSAND) 86
TABLE 27 GLOBAL AGROCHEMICAL INDUSTRY IN GAMMA BUTYROLACTONE MARKET, BY REGION, 2017-2030 (USD THOUSAND) 87
TABLE 28 GLOBAL PETROLEUM INDUSTRY IN GAMMA BUTYROLACTONE MARKET, BY REGION, 2017-2030 (USD THOUSAND) 88
TABLE 29 GLOBAL FOOD INDUSTRY IN GAMMA BUTYROLACTONE MARKET, BY REGION, 2017-2030 (USD THOUSAND) 88
TABLE 30 GLOBAL OTHERS IN GAMMA BUTYROLACTONE MARKET, BY REGION, 2017-2030 (USD THOUSAND) 89
TABLE 31 GLOBAL GAMMA BUTYROLACTONE MARKET, BY REGION, 2017-2030 (USD THOUSAND) 95
TABLE 32 GLOBAL GAMMA BUTYROLACTONE MARKET, BY REGION, 2017-2030 (TONS) 95
TABLE 33 ASIA-PACIFIC GAMMA BUTYROLACTONE MARKET, BY COUNTRY, 2017-2030 (USD THOUSAND) 99
TABLE 34 ASIA-PACIFIC GAMMA BUTYROLACTONE MARKET, BY COUNTRY, 2017-2030 (TONS) 99
TABLE 35 ASIA-PACIFIC GAMMA BUTYROLACTONE MARKET, BY GRADE, 2017-2030 (USD THOUSAND) 100
TABLE 36 ASIA-PACIFIC GAMMA BUTYROLACTONE MARKET, BY GRADE, 2017-2030 (TONS) 100
TABLE 37 ASIA-PACIFIC GAMMA BUTYROLACTONE MARKET, BY PURITY, 2017-2030 (USD THOUSAND) 100
TABLE 38 ASIA-PACIFIC GAMMA BUTYROLACTONE MARKET, BY APPLICATION, 2017-2030 (USD THOUSAND) 101
TABLE 39 ASIA-PACIFIC GAMMA BUTYROLACTONE MARKET, BY END-USE, 2017-2030 (USD THOUSAND) 101
TABLE 40 CHINA GAMMA BUTYROLACTONE MARKET, BY GRADE, 2017-2030 (USD THOUSAND) 102
TABLE 41 CHINA GAMMA BUTYROLACTONE MARKET, BY GRADE, 2017-2030 (TONS) 102
TABLE 42 CHINA GAMMA BUTYROLACTONE MARKET, BY PURITY, 2017-2030 (USD THOUSAND) 102
TABLE 43 CHINA GAMMA BUTYROLACTONE MARKET, BY APPLICATION, 2017-2030 (USD THOUSAND) 103
TABLE 44 CHINA GAMMA BUTYROLACTONE MARKET, BY END-USE, 2017-2030 (USD THOUSAND) 103
TABLE 45 INDIA GAMMA BUTYROLACTONE MARKET, BY GRADE, 2017-2030 (USD THOUSAND) 104
TABLE 46 INDIA GAMMA BUTYROLACTONE MARKET, BY GRADE, 2017-2030 (TONS) 104
TABLE 47 INDIA GAMMA BUTYROLACTONE MARKET, BY PURITY, 2017-2030 (USD THOUSAND) 104
TABLE 48 INDIA GAMMA BUTYROLACTONE MARKET, BY APPLICATION, 2017-2030 (USD THOUSAND) 105
TABLE 49 INDIA GAMMA BUTYROLACTONE MARKET, BY END-USE, 2017-2030 (USD THOUSAND) 105
TABLE 50 JAPAN GAMMA BUTYROLACTONE MARKET, BY GRADE, 2017-2030 (USD THOUSAND) 106
TABLE 51 JAPAN GAMMA BUTYROLACTONE MARKET, BY GRADE, 2017-2030 (TONS) 106
TABLE 52 JAPAN GAMMA BUTYROLACTONE MARKET, BY PURITY, 2017-2030 (USD THOUSAND) 106
TABLE 53 JAPAN GAMMA BUTYROLACTONE MARKET, BY APPLICATION, 2017-2030 (USD THOUSAND) 107
TABLE 54 JAPAN GAMMA BUTYROLACTONE MARKET, BY END-USE, 2017-2030 (USD THOUSAND) 107
TABLE 55 SOUTH KOREA GAMMA BUTYROLACTONE MARKET, BY GRADE, 2017-2030 (USD THOUSAND) 108
TABLE 56 SOUTH KOREA GAMMA BUTYROLACTONE MARKET, BY GRADE, 2017-2030 (TONS) 108
TABLE 57 SOUTH KOREA GAMMA BUTYROLACTONE MARKET, BY PURITY, 2017-2030 (USD THOUSAND) 108
TABLE 58 SOUTH KOREA GAMMA BUTYROLACTONE MARKET, BY APPLICATION, 2017-2030 (USD THOUSAND) 109
TABLE 59 SOUTH KOREA GAMMA BUTYROLACTONE MARKET, BY END-USE, 2017-2030 (USD THOUSAND) 109
TABLE 60 SINGAPORE GAMMA BUTYROLACTONE MARKET, BY GRADE, 2017-2030 (USD THOUSAND) 110
TABLE 61 SINGAPORE GAMMA BUTYROLACTONE MARKET, BY GRADE, 2017-2030 (TONS) 110
TABLE 62 SINGAPORE GAMMA BUTYROLACTONE MARKET, BY PURITY, 2017-2030 (USD THOUSAND) 110
TABLE 63 SINGAPORE GAMMA BUTYROLACTONE MARKET, BY APPLICATION, 2017-2030 (USD THOUSAND) 111
TABLE 64 SINGAPORE GAMMA BUTYROLACTONE MARKET, BY END-USE, 2017-2030 (USD THOUSAND) 111
TABLE 65 THAILAND GAMMA BUTYROLACTONE MARKET, BY GRADE, 2017-2030 (USD THOUSAND) 112
TABLE 66 THAILAND GAMMA BUTYROLACTONE MARKET, BY GRADE, 2017-2030 (TONS) 112
TABLE 67 THAILAND GAMMA BUTYROLACTONE MARKET, BY PURITY, 2017-2030 (USD THOUSAND) 112
TABLE 68 THAILAND GAMMA BUTYROLACTONE MARKET, BY APPLICATION, 2017-2030 (USD THOUSAND) 113
TABLE 69 THAILAND GAMMA BUTYROLACTONE MARKET, BY END-USE, 2017-2030 (USD THOUSAND) 113
TABLE 70 AUSTRALIA & NEW ZEALAND GAMMA BUTYROLACTONE MARKET, BY GRADE, 2017-2030 (USD THOUSAND) 114
TABLE 71 AUSTRALIA & NEW ZEALAND GAMMA BUTYROLACTONE MARKET, BY GRADE, 2017-2030 (TONS) 114
TABLE 72 AUSTRALIA & NEW ZEALAND GAMMA BUTYROLACTONE MARKET, BY PURITY, 2017-2030 (USD THOUSAND) 114
TABLE 73 AUSTRALIA & NEW ZEALAND GAMMA BUTYROLACTONE MARKET, BY APPLICATION, 2017-2030 (USD THOUSAND) 115
TABLE 74 AUSTRALIA & NEW ZEALAND GAMMA BUTYROLACTONE MARKET, BY END-USE, 2017-2030 (USD THOUSAND) 115
TABLE 75 INDONESIA GAMMA BUTYROLACTONE MARKET, BY GRADE, 2017-2030 (USD THOUSAND) 116
TABLE 76 INDONESIA GAMMA BUTYROLACTONE MARKET, BY GRADE, 2017-2030 (TONS) 116
TABLE 77 INDONESIA GAMMA BUTYROLACTONE MARKET, BY PURITY, 2017-2030 (USD THOUSAND) 116
TABLE 78 INDONESIA GAMMA BUTYROLACTONE MARKET, BY APPLICATION, 2017-2030 (USD THOUSAND) 117
TABLE 79 INDONESIA GAMMA BUTYROLACTONE MARKET, BY END-USE, 2017-2030 (USD THOUSAND) 117
TABLE 80 MALAYSIA GAMMA BUTYROLACTONE MARKET, BY GRADE, 2017-2030 (USD THOUSAND) 118
TABLE 81 MALAYSIA GAMMA BUTYROLACTONE MARKET, BY GRADE, 2017-2030 (TONS) 118
TABLE 82 MALAYSIA GAMMA BUTYROLACTONE MARKET, BY PURITY, 2017-2030 (USD THOUSAND) 118
TABLE 83 MALAYSIA GAMMA BUTYROLACTONE MARKET, BY APPLICATION, 2017-2030 (USD THOUSAND) 119
TABLE 84 MALAYSIA GAMMA BUTYROLACTONE MARKET, BY END-USE, 2017-2030 (USD THOUSAND) 119
TABLE 85 PHILIPPINES GAMMA BUTYROLACTONE MARKET, BY GRADE, 2017-2030 (USD THOUSAND) 120
TABLE 86 PHILIPPINES GAMMA BUTYROLACTONE MARKET, BY GRADE, 2017-2030 (TONS) 120
TABLE 87 PHILIPPINES GAMMA BUTYROLACTONE MARKET, BY PURITY, 2017-2030 (USD THOUSAND) 120
TABLE 88 PHILIPPINES GAMMA BUTYROLACTONE MARKET, BY APPLICATION, 2017-2030 (USD THOUSAND) 121
TABLE 89 PHILIPPINES GAMMA BUTYROLACTONE MARKET, BY END-USE, 2017-2030 (USD THOUSAND) 121
TABLE 90 REST OF ASIA-PACIFIC GAMMA BUTYROLACTONE MARKET, BY GRADE, 2017-2030 (USD THOUSAND) 122
TABLE 91 REST OF ASIA-PACIFIC GAMMA BUTYROLACTONE MARKET, BY GRADE, 2017-2030 (TONS) 122
TABLE 92 EUROPE GAMMA BUTYROLACTONE MARKET, BY COUNTRY, 2017-2030 (USD THOUSAND) 126
TABLE 93 EUROPE GAMMA BUTYROLACTONE MARKET, BY COUNTRY, 2017-2030 (TONS) 126
TABLE 94 EUROPE GAMMA BUTYROLACTONE MARKET, BY GRADE, 2017-2030 (USD THOUSAND) 127
TABLE 95 EUROPE GAMMA BUTYROLACTONE MARKET, BY GRADE, 2017-2030 (TONS) 127
TABLE 96 EUROPE GAMMA BUTYROLACTONE MARKET, BY PURITY, 2017-2030 (USD THOUSAND) 127
TABLE 97 EUROPE GAMMA BUTYROLACTONE MARKET, BY APPLICATION, 2017-2030 (USD THOUSAND) 128
TABLE 98 EUROPE GAMMA BUTYROLACTONE MARKET, BY END-USE, 2017-2030 (USD THOUSAND) 128
TABLE 99 FRANCE GAMMA BUTYROLACTONE MARKET, BY GRADE, 2017-2030 (USD THOUSAND) 129
TABLE 100 FRANCE GAMMA BUTYROLACTONE MARKET, BY GRADE, 2017-2030 (TONS) 129
TABLE 101 FRANCE GAMMA BUTYROLACTONE MARKET, BY PURITY, 2017-2030 (USD THOUSAND) 129
TABLE 102 FRANCE GAMMA BUTYROLACTONE MARKET, BY APPLICATION, 2017-2030 (USD THOUSAND) 130
TABLE 103 FRANCE GAMMA BUTYROLACTONE MARKET, BY END-USE, 2017-2030 (USD THOUSAND) 130
TABLE 104 GERMANY GAMMA BUTYROLACTONE MARKET, BY GRADE, 2017-2030 (USD THOUSAND) 131
TABLE 105 GERMANY GAMMA BUTYROLACTONE MARKET, BY GRADE, 2017-2030 (TONS) 131
TABLE 106 GERMANY GAMMA BUTYROLACTONE MARKET, BY PURITY, 2017-2030 (USD THOUSAND) 131
TABLE 107 GERMANY GAMMA BUTYROLACTONE MARKET, BY APPLICATION, 2017-2030 (USD THOUSAND) 132
TABLE 108 GERMANY GAMMA BUTYROLACTONE MARKET, BY END-USE, 2017-2030 (USD THOUSAND) 132
TABLE 109 U.K. GAMMA BUTYROLACTONE MARKET, BY GRADE, 2017-2030 (USD THOUSAND) 133
TABLE 110 U.K. GAMMA BUTYROLACTONE MARKET, BY GRADE, 2017-2030 (TONS) 133
TABLE 111 U.K. GAMMA BUTYROLACTONE MARKET, BY PURITY, 2017-2030 (USD THOUSAND) 133
TABLE 112 U.K. GAMMA BUTYROLACTONE MARKET, BY APPLICATION, 2017-2030 (USD THOUSAND) 134
TABLE 113 U.K. GAMMA BUTYROLACTONE MARKET, BY END-USE, 2017-2030 (USD THOUSAND) 134
TABLE 114 ITALY GAMMA BUTYROLACTONE MARKET, BY GRADE, 2017-2030 (USD THOUSAND) 135
TABLE 115 ITALY GAMMA BUTYROLACTONE MARKET, BY GRADE, 2017-2030 (TONS) 135
TABLE 116 ITALY GAMMA BUTYROLACTONE MARKET, BY PURITY, 2017-2030 (USD THOUSAND) 135
TABLE 117 ITALY GAMMA BUTYROLACTONE MARKET, BY APPLICATION, 2017-2030 (USD THOUSAND) 136
TABLE 118 ITALY GAMMA BUTYROLACTONE MARKET, BY END-USE, 2017-2030 (USD THOUSAND) 136
TABLE 119 TURKEY GAMMA BUTYROLACTONE MARKET, BY GRADE, 2017-2030 (USD THOUSAND) 137
TABLE 120 TURKEY GAMMA BUTYROLACTONE MARKET, BY GRADE, 2017-2030 (TONS) 137
TABLE 121 TURKEY GAMMA BUTYROLACTONE MARKET, BY PURITY, 2017-2030 (USD THOUSAND) 137
TABLE 122 TURKEY GAMMA BUTYROLACTONE MARKET, BY APPLICATION, 2017-2030 (USD THOUSAND) 138
TABLE 123 TURKEY GAMMA BUTYROLACTONE MARKET, BY END-USE, 2017-2030 (USD THOUSAND) 138
TABLE 124 BELGIUM GAMMA BUTYROLACTONE MARKET, BY GRADE, 2017-2030 (USD THOUSAND) 139
TABLE 125 BELGIUM GAMMA BUTYROLACTONE MARKET, BY GRADE, 2017-2030 (TONS) 139
TABLE 126 BELGIUM GAMMA BUTYROLACTONE MARKET, BY PURITY, 2017-2030 (USD THOUSAND) 139
TABLE 127 BELGIUM GAMMA BUTYROLACTONE MARKET, BY APPLICATION, 2017-2030 (USD THOUSAND) 140
TABLE 128 BELGIUM GAMMA BUTYROLACTONE MARKET, BY END-USE, 2017-2030 (USD THOUSAND) 140
TABLE 129 SPAIN GAMMA BUTYROLACTONE MARKET, BY GRADE, 2017-2030 (USD THOUSAND) 141
TABLE 130 SPAIN GAMMA BUTYROLACTONE MARKET, BY GRADE, 2017-2030 (TONS) 141
TABLE 131 SPAIN GAMMA BUTYROLACTONE MARKET, BY PURITY, 2017-2030 (USD THOUSAND) 141
TABLE 132 SPAIN GAMMA BUTYROLACTONE MARKET, BY APPLICATION, 2017-2030 (USD THOUSAND) 142
TABLE 133 SPAIN GAMMA BUTYROLACTONE MARKET, BY END-USE, 2017-2030 (USD THOUSAND) 142
TABLE 134 RUSSIA GAMMA BUTYROLACTONE MARKET, BY GRADE, 2017-2030 (USD THOUSAND) 143